Brief: Vivos Therapeutics Q1 Net Income USD -3.864 Million
15/05/2025 21:20
May 15 (Reuters) - Vivos Therapeutics Q1 operating income USD -3.918 million. Q1 basic EPS USD -0.45 Q1 operating expenses USD 5.427 million Q1 gross profit USD 1.509 million
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth